[ad_1] Image source: Getty Images As the race for jobs in what looks likely to be an Andy Burnham-led government gets under way, I thought I’d conduct a little challenge of my own. I’ve identified two FTSE 250 dividend stocks…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence International Seaways stock sank 6.2% Thursday despite a bullish upgrade from BTIG. Shares of the oil tanker operator fell to $82.24 on volume of 484,312 shares, moving sharply lower even as the firm…
[ad_1] Image source: Getty Images Never fall in love with a FTSE 100 stock. It’s always wise to keep a clear head about these things. Real money’s at stake. But I couldn’t help getting a little carried away by the…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Haemonetics Corporation surged 5.9% on Thursday, riding a strong wave higher across its sector peers. The medical devices company closed at $77.16 as investors piled into the group, with trading volume reaching 347,360…
[ad_1] Image source: Getty Images FTSE 100 share 3i Group (LSE:III) has endured a truly miserable time recently. The reason? Weaker-than-expected sales at Action, a European retailer and key plank of its investment portfolio. At £24.80 per share, 3i’s share…
[ad_1] AlphaStreet Newsdesk powered by AlphaStreet Intelligence Axcelis Technologies surged 5.8% Thursday as a powerful rally swept across semiconductor equipment makers, lifting the stock to $178.74 on heavy volume. The Beverly, Massachusetts-based company rode a sector-wide wave that saw four…
[ad_1] Image source: Rolls-Royce plc While the connection may not be immediately obvious, I believe Rolls‑Royce (LSE: RR.) shares could actually benefit from the AI sell‑off. And, unsurprisingly, SpaceX is part of that story. Should you buy Rolls-Royce Plc shares…
[ad_1] SoFi Technologies, Inc. (SOFI) is still described in some corners of the market as a student-loan refinancing fintech — a legacy label that increasingly misses what the company has become. Since obtaining a national bank charter in early 2022,…
[ad_1] Image source: Getty Images The thought of a stock market crash can be a scary one, especially for newer investors. And that’s understandable, as academic research has found that we’re wired to feel the sting of losses far more…
[ad_1] Moderna, Inc. (MRNA) is still discussed in many investor conversations as if the story ended when pandemic-era COVID vaccine revenues collapsed. It did not. The more durable debate is whether Moderna exits this trough phase with enough pipeline optionality…